JP Morgan maintains Xometry at Overweight, raises price target to $140 from $120

What happened

JP Morgan maintained its Overweight rating on Xometry and raised its price target to $140 from $120, a 16.7% increase. The new target implies 25.8% upside from the November 3 closing price of $111.29. Five recent analyst targets ranged from $114 to $140.

Confirmed

Global impact / market context

A higher target signals that JP Morgan sees more potential value in Xometry shares, which may influence investor expectations and trading decisions. The target is an analyst estimate, not a guaranteed share price or a change to Xometry’s reported business results.

Analyst inference

The recent analyst views are not identical: the five listed targets span $114 to $140, while ratings include Sector Perform, Outperform, Market Outperform, Buy, and Overweight. That spread points to differing judgments about Xometry’s prospects rather than a single agreed valuation.

Confirmed

What to watch

1. Compare future analyst target changes with company updates on revenue, costs, and business performance to see whether expectations are being supported by reported results. Analyst inference
2. Watch whether other analysts change their ratings or price targets; the current five-note range of $114 to $140 shows varied views. Analyst inference
3. Track Xometry’s share price against the $140 target and the cited $111.29 November 3 close; the article gives no subsequent price movement. Analyst inference

Evidence

• Original source link unavailable